Dr. Lal PathLabs Limited (LALPATHLAB.NS) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,836.10

Open1,835.00

Day range1,824.101,851.40

52-week range1,272.602,038.60

Off day high−0.71%

Off 52-week high−9.83%

Volume119.77K

Avg. volume (3M)348.20K

Market cap307.38B

EPS (TTM)32.53

Forward P/E41.89

P/E ratio (TTM)56.51

Dividend yield1.09% (20.00)

Beta (5Y)0.16

Shares outstanding167.21M

Short interest—

Earnings dateNov 4, 2026

Analyst target2,018.08

Profit margin18.75%

Against its peers

Compare in full ›

	LALPATHLAB.NS	4694.T	4544.T	LH	DHR	ICLR
Market cap	307.38B	145.62B	201.81B	26.26B	164.40B	14.29B
P/E (TTM)	56.5	18.6	21.8	26.8	41.7	195.0
Forward P/E	41.9	26.1	36.6	16.4	25.2	15.7
Price/book	12.2	1.1	1.5	3.0	3.1	1.5
Dividend yield	1.09%	3.25%	3.36%	0.89%	0.71%	—
1-year change	+17.57%	+5.77%	−6.21%	+14.24%	+2.82%	−9.56%
Today	+0.12%	+0.91%	+0.43%	+0.19%	+4.29%	+6.35%

The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Dr. Lal PathLabs's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
BML, Inc.4694.T · Diagnostics & Research	145.62B	3,885.00	+0.91%
H.U. Group Holdings, Inc.4544.T · Diagnostics & Research	201.81B	3,734.00	+0.43%
Labcorp Holdings Inc.LH · Diagnostics & Research Odds	26.26B	323.75	+0.19%
Danaher CorporationDHR · Diagnostics & Research	164.40B	233.86	+4.29%
ICON Public Limited CompanyICLR · Diagnostics & Research	14.29B	185.25	+6.35%
Quest Diagnostics IncorporatedDGX · Diagnostics & Research	26.37B	238.93	+0.76%
Medpace Holdings, Inc.MEDP · Diagnostics & Research	18.49B	662.48	+6.43%
bioMérieux S.A.BIM.PA · Diagnostics & Research	10.15B	86.25	−1.09%

Other companies in Diagnostics & Research, closest in size first.

Company	Mkt cap	Price	Today
Thermo Fisher Scientific Inc.TMO · Waltham, MA	256.61B	694.02	+0.97%
H.U. Group Holdings, Inc.4544.T · Tokyo, Japan	201.81B	3,734.00	+0.43%
Danaher CorporationDHR · Washington, DC	164.40B	233.86	+4.29%
WuXi AppTec Co., Ltd.2359.HK · Shanghai, China	556.30B	183.300	−6.48%
BML, Inc.4694.T · Tokyo, Japan	145.62B	3,885.00	+0.91%
Shin Nippon Biomedical Laboratories, Ltd.2395.T · Kagoshima, Japan	61.07B	1,467.00	+0.20%
Natera, Inc.NTRA · Austin, TX Odds	59.59B	413.38	+1.84%
Agilent Technologies, Inc.A · Santa Clara, CA	50.12B	177.75	+2.74%

Healthcare companies of a similar market value (308.29B).

Company	Mkt cap	Price	Today
Roche Holding AGROP.SW · Drug Manufacturers - General	312.33B	392.00	+0.54%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd600276.SS · Drug Manufacturers - Specialty & Generic	307.83B	46.38	−2.11%
Wockhardt LimitedWOCKPHARMA.BO · Drug Manufacturers - Specialty & Generic	307.27B	1,891.00	+0.88%
Bangkok Dusit Medical Services Public Company LimitedBDMS.BK · Medical Care Facilities	306.72B	19.30	−1.03%
BeOne Medicines AG6160.HK · Biotechnology	330.41B	223.400	−3.46%
Novartis AGNVS · Drug Manufacturers - General	292.58B	153.93	+0.19%
Emcure Pharmaceuticals LimitedEMCURE.BO · Drug Manufacturers - Specialty & Generic	333.32B	1,757.00	+0.06%
Merck & Co., Inc.MRK · Drug Manufacturers - General Odds	369.78B	149.88	+1.07%

Also based in Gurugram, India, then elsewhere in India.

Company	Mkt cap	Price	Today
Bharti Airtel LimitedBHARTIARTL.NS · Gurugram, India	11.90T	1,907.20	+0.82%
Nestlé India LimitedNESTLEIND.BO · Gurugram, India	2.31T	1,195.75	−1.91%
InterGlobe Aviation LimitedINDIGO.BO · Gurugram, India	1.78T	4,613.75	−0.45%
DLF LimitedDLF.BO · Gurugram, India	1.65T	667.10	+0.66%
Varun Beverages LimitedVBL.BO · Gurugram, India	1.36T	402.25	−1.70%
Lenskart Solutions LimitedLENSKART.NS · Gurugram, India	1.09T	628.90	−0.39%
Indus Towers LimitedINDUSTOWER.NS · Gurugram, India	1.01T	382.20	+0.84%
Max Healthcare Institute LimitedMAXHEALTH.BO · Gurugram, India	783.08B	804.55	−1.89%

What visitors to Dr. Lal PathLabs's page also look at.

Company	Mkt cap	Price	Today
METROPOLIS HEALTHCARE LTDMETROPOLIS.NS	110.38B	532.05	−0.29%
ALKEM LABORATORIES LTD.ALKEM.NS	595.19B	4,978.00	−0.74%
ASTRAL LIMITEDASTRAL.NS	366.71B	1,365.00	−2.21%
ABBOTT INDIA LIMITEDABBOTINDIA.NS	541.22B	25,470.00	−0.82%
APOLLO HOSPITALS ENTER. LAPOLLOHOSP.NS	1.08T	7,501.50	−1.30%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All LALPATHLAB.NS news ›

Udaipur Kiran·Oct 14Positive

Dr. Lal Pathlabs rises as its arm acquires remaining 30% stake in Centrapath Labs

Mumbai, October 14 (Udaipur Kiran): Dr. Lal Pathlabs is currently trading at Rs. 1928.20, up by 16.70 points or 0.87% from its previous closing of Rs. 1911.50 on the BSE. The scrip opened at Rs. 1909.00 and has touched a high and low of…

Moneycontrol·Oct 12Positive

Axis Direct bullish on Dr Lal PathLabs, Vijaya Diagnostic and Nephrocare, assigns 'Buy' ratings with up to 21% upside

Axis Direct is bullish on Dr Lal PathLabs, Vijaya Diagnostic Centre and Nephrocare Health Services, assigning 'Buy' ratings to all three stocks and setting target prices that imply an upside of up to 21%, citing structural growth drivers…

Free Press Journal·Oct 12

Dr. Lal PathLabs Invests Up To ₹30.3 Crore In Wholly Owned Subsidiary PUPL

Dr. Lal PathLabs has made a further investment of up to ₹30.3 crore in its wholly owned subsidiary, PathLabs Unifiers Private Limited (PUPL). The investment involves a cash consideration not exceeding ₹30.3 crore. PUPL will continue to…

Business Upturn·Oct 12Positive

Dr. Lal PathLabs invests up to INR 30.3 crore in PathLabs Unifiers

Dr. Lal PathLabs Limited, a prominent entity in the healthcare and diagnostics sector, has announced a further investment into its wholly owned subsidiary, PathLabs Unifiers Private Limited (PUPL). The investment, made by subscribing to…

BusinessLine·Oct 8Negative

Income Tax Dept. appeals against tax relief favouring Dr Lal PathLabs; stock falls 2.4%

Dr Lal PathLabs said the Income Tax Department has appealed to the ITAT against an earlier order granting the company relief on ₹32.66 crore in ESOP expenses for assessment year 2022-23. Dr Lal PathLabs Limited disclosed on Thursday that…

From articles in the 4Search news index.

In the news

19mentions in 30 days

19with it in the headline

Positivesentiment

Most coverage from

thehindubusinessline.com4
tradingview.com4
moneycontrol.com2
business-standard.com1
businessupturn.com1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 19 articles, not a forecast.